Cullinan Oncology Inc

NASDAQ:CGEM  
11.47
+0.91 (+8.62%)
Mergers / Acquisitions

Cullinan And Taiho To Jointly Develop And Commercialize Cln-081/Tas6417 And Taiho's Acquisition Of Cullinan Pearl

Published: 05/12/2022 06:14 GMT
Cullinan Oncology Inc (CGEM) - Cullinan Oncology and Taiho Pharmaceutical Announce Strategic Collaboration to Jointly Develop and Commercialize Cln-081/tas6417 and Taiho's Acquisition of Cullinan Pearl.